We originally proposed protein kinase CK2 as a target for cancer therapy [8, 9], which meets the first three of the above-mentioned requirements for a cancer therapy target but not the fourth as CK2 is present ubiquitously in all cells. The gene discussed is WEE1; the disease is cancer.